MedTrace Logo

Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation

NCT05890430 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 570

Last updated 2023-06-08

No results posted yet for this study

Summary

We will study a prospective cohort including all kidney transplant recipients undergoing kidney graft biopsy in one kidney transplantation center, for a duration of 5 years.

Our primary outcome is to compare the number of circulating NK cells between patients and without humoral rejection.

Our secondary outcomes are to describe the cellular, genetic, humoral, and histological characteristics of humoral rejection and their evolution.

Conditions

  • Kidney Transplantation
  • Kidney Allograft Biopsy
  • Humoral Rejection
  • Microvascular Inflammation

Interventions

BIOLOGICAL

Blood draw, Urine draw

Collection of an additional volume of blood at each follow-up time in addition to the standard blood test performed during the patient's follow-up Collection of an additional volume of urine at each follow-up time

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2033-06-30
Completion
2033-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05890430 on ClinicalTrials.gov